PLASMACAP EBA Trademark

Trademark Overview


On Thursday, July 25, 2013, a trademark application was filed for PLASMACAP EBA with the United States Patent and Trademark Office. The USPTO has given the PLASMACAP EBA trademark a serial number of 86019802. The federal status of this trademark filing is REGISTERED as of Tuesday, October 13, 2020. This trademark is owned by Therapure Biopharma Inc.. The PLASMACAP EBA trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, Construction & Repair Services, Treatment & Processing of Materials Services, Education & Entertainment Services, and Computer & Software Services & Scientific Services categories with the following description:

Resins, namely, polysaccharide beads cross-linked to ligands for capturing proteins from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate ion exchange, mixed mode, and affinity resins

Biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for human clinical use, namely, plasma protein fractions, serum albumin, immunoglobulins, coagulation factors, antihemophilic factors, clotting factors, enzymes, coenzymes, coactivators, inhibitors, and structural proteins

Protein chromatography equipment for capturing biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate

Construction of biopharmaceutical and plasma manufacturing facilities relevant to the manufacturing of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate; consulting services in the field of construction of biopharmaceutical and plasma manufacturing services

Contract manufacturing services for others for biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development, and clinical use; consulting services concerning manufacturing of biologics

Educational services, namely, designing, arranging, and conducting training programs for research and development, manufacturing of biologics, design, construction, and use of chromatography equipment

Development of pharmaceutical preparations and medicines, namely, development services for others for the capture of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development; consulting services for others concerning the capture of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development, design of chromatography equipment, and design of biopharmaceutical and plasma manufacturing facilities, namely, scientific research and evaluation, and engineering
plasmacap eba

General Information


Serial Number86019802
Word MarkPLASMACAP EBA
Filing DateThursday, July 25, 2013
Status700 - REGISTERED
Status DateTuesday, October 13, 2020
Registration Number6172149
Registration DateTuesday, October 13, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 28, 2020

Trademark Statements


Disclaimer with Predetermined Text"EBA"
Goods and ServicesResins, namely, polysaccharide beads cross-linked to ligands for capturing proteins from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate ion exchange, mixed mode, and affinity resins
Goods and ServicesBiologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for human clinical use, namely, plasma protein fractions, serum albumin, immunoglobulins, coagulation factors, antihemophilic factors, clotting factors, enzymes, coenzymes, coactivators, inhibitors, and structural proteins
Goods and ServicesProtein chromatography equipment for capturing biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate
Goods and ServicesConstruction of biopharmaceutical and plasma manufacturing facilities relevant to the manufacturing of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate; consulting services in the field of construction of biopharmaceutical and plasma manufacturing services
Goods and ServicesContract manufacturing services for others for biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development, and clinical use; consulting services concerning manufacturing of biologics
Goods and ServicesEducational services, namely, designing, arranging, and conducting training programs for research and development, manufacturing of biologics, design, construction, and use of chromatography equipment
Goods and ServicesDevelopment of pharmaceutical preparations and medicines, namely, development services for others for the capture of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development; consulting services for others concerning the capture of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development, design of chromatography equipment, and design of biopharmaceutical and plasma manufacturing facilities, namely, scientific research and evaluation, and engineering
Pseudo MarkPLASMA CAP EBA

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, June 18, 2020
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 30, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateWednesday, February 19, 2014
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class037 - Building construction; repair; installation services.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateWednesday, February 19, 2014
Primary Code037
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateWednesday, February 19, 2014
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateWednesday, February 19, 2014
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, July 30, 2013
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEvolve Biologics Inc.,
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMississauga, Ontario L5N 8G6
CA

Party NameTherapure Biopharma Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMississauga, Ontario L5N8H9
CA

Party NameTherapure Biopharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMississauga, Ontario L5N8H9
CA

Trademark Events


Event DateEvent Description
Tuesday, July 6, 2021REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Thursday, July 1, 2021TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, October 13, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, July 28, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 28, 2020PUBLISHED FOR OPPOSITION
Wednesday, July 8, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, June 18, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 17, 2020PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Wednesday, June 17, 2020TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, June 2, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 2, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 2, 2020TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, January 1, 2020ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, December 3, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, December 3, 2019FINAL REFUSAL E-MAILED
Tuesday, December 3, 2019FINAL REFUSAL WRITTEN
Wednesday, November 27, 2019ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Friday, October 25, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 25, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 24, 2019TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, October 23, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, October 22, 2019TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, September 27, 2019NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, September 27, 2019INQUIRY TO SUSPENSION E-MAILED
Friday, September 27, 2019SUSPENSION INQUIRY WRITTEN
Monday, September 9, 2019LIE CHECKED SUSP - TO ATTY FOR ACTION
Tuesday, February 5, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, February 5, 2019LETTER OF SUSPENSION E-MAILED
Tuesday, February 5, 2019SUSPENSION LETTER WRITTEN
Friday, December 7, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 7, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 6, 2018TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, June 8, 2018NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, June 8, 2018INQUIRY TO SUSPENSION E-MAILED
Friday, June 8, 2018SUSPENSION INQUIRY WRITTEN
Wednesday, May 30, 2018LIE CHECKED SUSP - TO ATTY FOR ACTION
Friday, November 24, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, November 24, 2017LETTER OF SUSPENSION E-MAILED
Friday, November 24, 2017SUSPENSION LETTER WRITTEN
Tuesday, October 10, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 10, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 4, 2017TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, April 20, 2017NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, April 20, 2017INQUIRY TO SUSPENSION E-MAILED
Thursday, April 20, 2017SUSPENSION INQUIRY WRITTEN
Friday, March 17, 2017LIE CHECKED SUSP - TO ATTY FOR ACTION
Tuesday, September 13, 2016NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, September 13, 2016LETTER OF SUSPENSION E-MAILED
Tuesday, September 13, 2016SUSPENSION LETTER WRITTEN
Tuesday, August 16, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 16, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 8, 2016TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, February 9, 2016NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, February 9, 2016INQUIRY TO SUSPENSION E-MAILED
Tuesday, February 9, 2016SUSPENSION INQUIRY WRITTEN
Wednesday, December 16, 2015LIE CHECKED SUSP - TO ATTY FOR ACTION
Saturday, May 30, 2015NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Saturday, May 30, 2015LETTER OF SUSPENSION E-MAILED
Saturday, May 30, 2015SUSPENSION LETTER WRITTEN
Tuesday, April 28, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 28, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 23, 2015TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Saturday, October 25, 2014NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Saturday, October 25, 2014INQUIRY TO SUSPENSION E-MAILED
Saturday, October 25, 2014SUSPENSION INQUIRY WRITTEN
Wednesday, September 24, 2014LIE CHECKED SUSP - TO ATTY FOR ACTION
Monday, March 24, 2014NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, March 24, 2014LETTER OF SUSPENSION E-MAILED
Monday, March 24, 2014SUSPENSION LETTER WRITTEN
Wednesday, February 19, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 19, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 12, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 11, 2014ASSIGNED TO LIE
Sunday, February 9, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, November 14, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 14, 2013NON-FINAL ACTION E-MAILED
Thursday, November 14, 2013NON-FINAL ACTION WRITTEN
Thursday, November 7, 2013ASSIGNED TO EXAMINER
Wednesday, July 31, 2013NOTICE OF PSEUDO MARK E-MAILED
Tuesday, July 30, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, July 29, 2013NEW APPLICATION ENTERED IN TRAM